Cover ImageSALE
市場調查報告書

免疫學的全球市場:2018年∼2022年

Global Immunology Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 599692
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
免疫學的全球市場:2018年∼2022年 Global Immunology Market 2018-2022
出版日期: 2018年01月08日 內容資訊: 英文 117 Pages
簡介

關於免疫學

免疫系統,保護身體不受病毒、細菌、癌症等侵害。那是細胞,分子的網路,在身體全體存在的器官。免疫系統,攻擊在體內存在的異物。身體確認含癌症性細胞的異常細胞並破壞。固有的自我防衛系統,包含鑑定外來分子中幫助身體的細胞。不同的途徑,為了區別身體健康細胞和病毒(寄生蟲,細菌,真菌,及癌症細胞)的病原性外來物質,調節各種免疫細胞。身體為了對用各種方法打算攻擊並持續進化的生物維持身體的防止,免疫系統的全部結構要素必須持續改變。有時持續改變的免疫系統,將其視為外來的敵人,對體細胞起反應,破壞了健康的組織,成為自體免疫疾病及癌症的原因。由於引起免疫不全症的遺傳性理由身體的防衛變弱,也觀察到沒反應的固有狀態。

Technavio的分析師預測,從2018年到在2222年之間,全球免疫學市場將以4.57%的年複合成長率成長。

本報告提供全球市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 簡介

  • 市場概要

第5章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第6章 市場規模

  • 市場定義
  • 市場規模:2017年
  • 市場規模與預測

第7章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情形

第8章 開發平台的風景

第9章 市場區隔:各類別

  • 市場區隔:各類別
  • 比較:各類別
  • 免疫抑制劑市場
  • 抗原抗體反應催化劑(Immuno Booster)市場
  • 市場機會:各類別

第10章 市場區隔:各表示

  • 自體免疫疾病
  • 腫瘤學
  • 器官移植
  • 其他

第11章 客戶形勢

第12章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第13章 決策架構

第14章 成長要素與課題

  • 市場成長要素
  • 市場課題

第15章 市場趨勢

  • 重要的開發平台
  • R&D的共同研究和合作關係
  • 先進診斷技術

第16章 業者情勢

  • 概要
  • 創造性破壞

第17章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

第18章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR20037

About Immunology

The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.

Technavio's analysts forecast the global immunology market to grow at a CAGR of 4.57% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunology market for 2018-2022. To calculate the market size, the report considers the revenue generated from the immunology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Immunology Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

Other Prominent Vendors

  • Angimmune
  • Bionor Pharma
  • Boston Biomedical
  • Celgene
  • Cellectar Biosciences
  • eFFECTOR Therapeutics
  • Forty Seven
  • HANSOH
  • Immatics Biatechnologies
  • lmmunovaccine
  • Karyopharm Therapeutics
  • MabVax Therapeutics
  • MedImmune
  • MOLOGEN
  • Neon Therapeutics
  • NewLink Genetics
  • Novartis
  • ONCOQUEST
  • Oncotherapeutics.

Market driver

  • Growing cases of infectious diseases
  • For a full, detailed list, view our report

Market trend

  • Significant pipeline
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: PIPELINE LANDSCAPE

PART 09: MARKET SEGMENTATION BY CATEGORY

  • Segmentation by category
  • Comparison by category
  • Global immunosuppressants market
  • Global immuno boosters market
  • Market opportunity by category

PART 10: MARKET SEGMENTATION BY INDICATION

  • Autoimmune diseases
  • Oncology
  • Organ transplantation
  • Others

PART 11: CUSTOMER LANDSCAPE

PART 12: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Immunology market in Americas
  • Immunology market in EMEA
  • Immunology market in APAC
  • Market opportunity

PART 13: DECISION FRAMEWORK

PART 14: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 15: MARKET TRENDS

  • Significant pipeline
  • Collaborations and partnerships for R&D
  • Advanced diagnostic technologies

PART 16: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 17: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AbbVie
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson

PART 18: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global immunology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global immunology market 2017-2022 ($ billions)
  • Exhibit 09: Global immunology market: Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Pipeline landscape by development phase
  • Exhibit 19: Key clinical trials
  • Exhibit 20: Global immunology market by category 2017-2022 (%)
  • Exhibit 21: Comparison by category
  • Exhibit 22: Immunosuppressant drugs
  • Exhibit 23: Global immunosuppressants market 2017-2022 ($ billions)
  • Exhibit 24: Global immunosuppressants market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Classification of immuno boosters
  • Exhibit 26: Global immuno boosters market 2017-2022 ($ billions)
  • Exhibit 27: Global immuno boosters market: Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by category
  • Exhibit 29: Brief history of immuno-oncology
  • Exhibit 30: Stages of anti-tumor immune response
  • Exhibit 31: Customer landscape
  • Exhibit 32: Global immunology market by geography 2017-2022 (%)
  • Exhibit 33: Regional comparison
  • Exhibit 34: Immunology market in Americas 2017-2022 ($ billions)
  • Exhibit 35: Immunology market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top three countries in Americas
  • Exhibit 37: Immunology market in EMEA 2017-2022 ($ billions)
  • Exhibit 38: Immunology market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Top three countries in EMEA
  • Exhibit 40: Immunology market in APAC 2017-2022 ($ billions)
  • Exhibit 41: Immunology market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 42: Top three countries in APAC
  • Exhibit 43: Market opportunity
  • Exhibit 44: Rise in organ transplantation in US 2015-2016
  • Exhibit 45: Organ transplantation by donor type 2016
  • Exhibit 46: Vendor landscape
  • Exhibit 47: Landscape disruption
  • Exhibit 48: Vendors covered
  • Exhibit 49: Vendor classification
  • Exhibit 50: Market positioning of vendors
  • Exhibit 51: AbbVie: Vendor overview
  • Exhibit 52: AbbVie: Business segments
  • Exhibit 53: AbbVie: Organizational developments
  • Exhibit 54: AbbVie: Geographic focus
  • Exhibit 55: AbbVie: Segment focus
  • Exhibit 56: AbbVie: Key offerings
  • Exhibit 57: Amgen: Vendor overview
  • Exhibit 58: Amgen: Business segments
  • Exhibit 59: Amgen: Organizational developments
  • Exhibit 60: Amgen: Geographic focus
  • Exhibit 61: Amgen: Segment focus
  • Exhibit 62: Amgen: Key offerings
  • Exhibit 63: F. Hoffmann-La Roche: Vendor overview
  • Exhibit 64: F. Hoffmann-La Roche: Business segments
  • Exhibit 65: F. Hoffman-La Roche: Organizational developments
  • Exhibit 66: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 67: F. Hoffmann-La Roche: Segment focus
  • Exhibit 68: F. Hoffmann-La Roche: Key offerings
  • Exhibit 69: Johnson & Johnson: Vendor overview
  • Exhibit 70: Johnson & Johnson: Business segments
  • Exhibit 71: Johnson & Johnson: Organizational developments
  • Exhibit 72: Johnson & Johnson: Geographic focus
  • Exhibit 73: Johnson & Johnson: Segment focus
  • Exhibit 74: Johnson & Johnson: Key offerings
Back to Top